Cargando…

Cerebral infarction following administration of andexanet alfa for anticoagulant reversal in a patient with traumatic acute subdural hematoma

BACKGROUND: Anticoagulants prevent thrombosis in patients with atrial fibrillation (AF) and venous thromboembolism but increase the risk of hemorrhagic complications. If severe bleeding occurs with anticoagulant use, discontinuation and rapid reversal are essential. However, the optimal timing for r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagai, Arata, Karibe, Hiroshi, Narisawa, Ayumi, Kameyama, Motonobu, Ishikawa, Shuichi, Iwabuchi, Naoya, Tominaga, Teiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Scientific Scholar 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481803/ https://www.ncbi.nlm.nih.gov/pubmed/37680936 http://dx.doi.org/10.25259/SNI_358_2023

Ejemplares similares

Incidence of Chronic Subdural Hematoma after Mild Head Trauma in Elderly Patients with or without Pre-traumatic Conditioning of Anti-thrombotic Drugs
por: KARIBE, Hiroshi, et al.
Publicado: (2023)

Acute Subdural Hematoma in Infants with Abusive Head Trauma: A Literature Review
por: KARIBE, Hiroshi, et al.
Publicado: (2016)

Surgical Management of Traumatic Acute Subdural Hematoma in Adults: A Review
por: KARIBE, Hiroshi, et al.
Publicado: (2014)

Clinical Characteristics and Outcome in Elderly Patients with Traumatic Brain Injury: For Establishment of Management Strategy
por: KARIBE, Hiroshi, et al.
Publicado: (2017)

Mutism resulting from heterochronic bilateral cerebellar hemorrhages – A case report
por: Katsuki, Masahito, et al.
Publicado: (2019)

Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation
por: Carpenter, Elise, et al.
Publicado: (2019)

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
por: Hu, Tiffany Y, et al.
Publicado: (2016)

Andexanet Alfa: First Global Approval
por: Heo, Young-A
Publicado: (2018)

Institutional Experience of Using Andexanet Alfa
por: Khadka, Sushmita, et al.
Publicado: (2020)

Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban
por: Benz, Alexander P., et al.
Publicado: (2022)

Correction to: Andexanet Alfa: First Global Approval
por: Heo, Young-A
Publicado: (2018)

Difficult Intraoperative Heparinization Following Andexanet Alfa Administration
por: Watson, C. James, et al.
Publicado: (2019)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
por: Lewis, Joseph, et al.
Publicado: (2022)

Successful use of an antithrombin for heparin resistance with andexanet alfa
por: Honda, Jun, et al.
Publicado: (2023)

Traumatic Spinal Subdural Hematoma with Intracranial Subdural Hematoma
por: Kim, Hyun Gon, et al.
Publicado: (2014)

Reversing factor Xa inhibitors – clinical utility of andexanet alfa
por: Kaatz, Scott, et al.
Publicado: (2017)

Andexanet-Alfa-Associated Heparin Resistance in the Context of Hemorrhagic Stroke
por: Müther, Michael, et al.
Publicado: (2022)

Andexanet alfa — Recommendations for clinical use. Multidisciplinary experts’ standpoint
por: Kubica, Jacek, et al.
Publicado: (2023)

Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model
por: Lu, Genmin, et al.
Publicado: (2018)

Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures
por: Bradshaw, Paige Garber, et al.
Publicado: (2022)

Successful Nafamostat Mesilate Administration for Andexanet Alfa-Induced Heparin Resistance
por: Kitaura, Atsuhiro, et al.
Publicado: (2023)

Traumatic Retroclival Subdural Hematoma
por: Van der Stricht, Tom, et al.
Publicado: (2023)

Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

How will UK hospitals use andexanet alfa? A review of local protocols
por: Glancy, Paula, et al.
Publicado: (2023)

Organized Chronic Subdural Hematoma: A Condition Presenting Mixed-Density Hematoma without Gradation Density on Brain CT
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Thirty‐day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life‐threatening direct oral anticoagulant‐related bleeding
por: Cohen, Alexander T., et al.
Publicado: (2022)

Evaluation of oral factor Xa inhibitor‐associated extracranial bleeding reversal with andexanet alfa
por: Nederpelt, Charlie J., et al.
Publicado: (2020)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study
por: Rauch, Sebastian, et al.
Publicado: (2022)

Antiplatelet/Anticoagulant Agents and Chronic Subdural Hematoma in the Elderly
por: De Bonis, Pasquale, et al.
Publicado: (2013)

Functional Outcome in Patients with Chronic Subdural Hematoma: Postoperative Delirium and Operative Procedure
por: ISHIDA, Tomohisa, et al.
Publicado: (2022)

Expression of the TGF-β–ALK-1 Pathway in Dura and the Outer Membrane of Chronic Subdural Hematomas
por: SAITO, Atsushi, et al.
Publicado: (2014)

Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

Rapid Detection of Apixaban by a ROTEM-Based Approach and Reversibility with Andexanet Alfa or DOAC-Stop
por: Taune, Viktor, et al.
Publicado: (2022)

Endoscopic Surgery for Traumatic Acute Subdural Hematoma
por: Kon, Hiroyuki, et al.
Publicado: (2014)

Neurocritical Management of Traumatic Acute Subdural Hematomas
por: Shin, Dong-Seong, et al.
Publicado: (2020)

Blood Pressure Control in Traumatic Subdural Hematomas
por: Hallan, David R
Publicado: (2022)

The impact of oral anticoagulants on the characteristics of subdural hematomas and other brain lesions in patients with traumatic brain injury
por: Pastor, Iulia-Sevastiana, et al.
Publicado: (2023)

Spontaneous Development of Encapsulated Subdural Hematoma in the Posterior Cranial Fossa after Cardiac Surgery: A Case Report
por: Kochi, Ryuzaburo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o3akbga8hbjku01l0vsmsk0kbo